Millipore continues buying spree with NovAseptic acquisition

Millipore is buying Sweden's NovAseptic for $91 million in cash. The deal gives Millipore the NovaSeptum technology for taking fluid samples during the drug manufacturing process. It reportedly provides fewer false positives of contaminants which are regularly assessed. Yesterday, Millipore announced it was buying MicroSafe, a Dutch contract laboratory, for $9.3 million.

- red this report from MassHighTech for more

Suggested Articles

The FDA rejected the New Drug Application for golodirsen, the follow-up to Exondys 51, Sarepta’s first treatment for Duchenne muscular dystrophy.

Levi Garraway is set to take up one of the biggest hot seats in biopharma when he becomes the next chief medical officer at Roche.

Vanda Pharmaceuticals received a Complete Response Letter from the FDA taking issue with a small study testing Hetlioz in jet lag disorder.